Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NORPROLAC DIN 02223767

Status: Cancelled Post Market
Holder: FERRING INC
Molecule: QUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE)

Health Canada record

Active ingredient(s)QUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE) 0.075 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCG02CB04 QUINAGOLIDE
Original market date29-Dec-2004
Current status date09-Dec-2020
SourceHealth Canada DPD

Establishment licence of the holder

Ferring Inc. — licence 100274, currently licensed, last inspection rating C (2026-05-19).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing QUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE)

DINProductCompanyFormStrengthStatus
02223740NORPROLACFERRING INCTabletQUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE) 0.025 MGCancelled Post Market
02223759NORPROLACFERRING INCTabletQUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE) 0.05 MGCancelled Post Market
02223775NORPROLACFERRING INCTabletQUINAGOLIDE (QUINAGOLIDE HYDROCHLORIDE) 0.15 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
1532004-03-15New Drug Submission (NDS)MANUFACTURER NAME CHANGE
46061996-06-25New Drug Submission (NDS)
Request a quote for NORPROLAC

How to read a Canadian DIN record